ArticleCancer medicine2024

A multicenter, real-world study on effectiveness and safety of first-line modified PD-1 inhibitors with chemotherapy in advanced non-small cell lung cancer (aNSCLC) with drive gene-negative.

Tao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.